Brief: EyeGene receives patent
Jan 12 (Reuters) - EyeGene Inc 185490.KQ :
* Says it received U.S. patent on Jan. 12, for vaccines for
cervical cancer
* Says patent number is 13/379,212
Source text in Korean: https://goo.gl/2SJe8v
Further company coverage: 185490.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on EyeGene
See all newsBrief: Eyegene Inc To Conduct Capital Increase Of 32 Billion Won For Operational Funds
Brief: Eyegene To Conduct Capital Increase Of 15 Billion Won For Operational Funds
Brief: EyeGene raises 11.5 bln won via private placement
Brief: EyeGene issues 2nd series convertible bonds worth 18.5 bln won
Brief: EyeGene receives patent